Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 12 Similar Profiles
Receptor, Serotonin, 5-HT1A
Medicine & Life Sciences
Serotonin
Medicine & Life Sciences
8-Hydroxy-2-(di-n-propylamino)tetralin
Medicine & Life Sciences
Catalepsy
Medicine & Life Sciences
Columbidae
Medicine & Life Sciences
Sodium Oxybate
Medicine & Life Sciences
Phencyclidine
Medicine & Life Sciences
Baclofen
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2003 2016
- 4 Finished
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
3/1/12 → 11/30/16
Project: Research project › Research Project
Antidepressive Agents
Cations
Serotonin
Membrane Transport Proteins
Cell Membrane
Vulnerability to Opioids: A Mouse Model
9/15/08 → 5/31/13
Project: Research project › Research Project
Opioid Analgesics
Morphine
Prescriptions
Rodentia
Public Health
Discriminative Stimulus Effects of Alcohol in Mice
9/30/06 → 8/31/09
Project: Research project › Exploratory/Developmental Grants
Alcohols
Substance-Related Disorders
Pharmaceutical Preparations
Alcoholism
Rodentia
Neuropharmacology
Sodium Oxybate
Baclofen
Pharmaceutical Preparations
Pharmacology
Research Output 1981 2019
Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter
Fraser-Spears, R., Krause-Heuer, A. M., Basiouny, M., Mayer, F. P., Manishimwe, R., Wyatt, N. A., Dobrowolski, J. C., Roberts, M. P., Greguric, I., Kumar, N., Koek, W., Sitte, H. H., Callaghan, P. D., Fraser, B. H. & Daws, L. C., Jan 5 2019, In : European Journal of Pharmacology. 842, p. 351-364 14 p.Research output: Contribution to journal › Article
Membrane Transport Proteins
Cations
Cell Membrane
Antidepressive Agents
nisoxetine
An unsuspected role for organic cation transporter 3 in the actions of amphetamine
Mayer, F. P., Schmid, D., Owens, W. A., Gould, G. G., Apuschkin, M., Kudlacek, O., Salzer, I., Boehm, S., Chiba, P., Williams, P. H., Wu, H. H., Gether, U., Koek, W., Daws, L. C. & Sitte, H. H., Apr 6 2018, (Accepted/In press) In : Neuropsychopharmacology. p. 1-10 10 p.Research output: Contribution to journal › Article
Amphetamine
Cations
Cocaine
Amphetamine-Related Disorders
Dopamine Plasma Membrane Transport Proteins
A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
Kraig, E. B., Linehan, L. A., Liang, H., Romo, T. Q., Liu, Q., Wu, Y., Benavides, A. D., Curiel, T. J., Javors, M. A., Musi, N., Chiodo, L., Koek, W., Gelfond, J. A. & Kellogg Jr, D. L., Jan 1 2018, (Accepted/In press) In : Experimental Gerontology.Research output: Contribution to journal › Article
Sirolimus
Safety
Therapeutics
Erythrocyte Indices
Clinical laboratories
Biphasic effects of selective serotonin reuptake inhibitors on anxiety: Rapid reversal of escitalopram's anxiogenic effects in the novelty-induced hypophagia test in mice?
Koek, W., Mitchell, N. C. & Daws, L. C., Jan 1 2018, In : Behavioural Pharmacology. 29, 4, p. 365-369 5 p.Research output: Contribution to journal › Article
Citalopram
Serotonin Uptake Inhibitors
Anxiety
Anti-Anxiety Agents
Survival Analysis
Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours
Gilman, T. L., George, C. M., Vitela, M., Herrera-Rosales, M., Basiouny, M. S., Koek, W. & Daws, L. C., Jul 1 2018, In : European Journal of Neuroscience. 48, 1, p. 1706-1716 11 p.Research output: Contribution to journal › Article
Membrane Transport Proteins
Psychological Adaptation
Anxiety
Cell Membrane
Knockout Mice
Press/Media
Potential new treatments and tools for understanding depression
7/6/17
2 items of media coverage
Press/Media: Press / Media
Australia Patent for '3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia' Ceases
5/13/17
1 item of media coverage
Press/Media: Press / Media
Australia Patent for '1,4-difunctionalized cyclohexane derivatives as ligands of 5-HT1A receptors' Ceases
5/28/16
1 item of media coverage
Press/Media: Press / Media
Australia Patent for '3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5HT1A receptors' Ceases
5/28/16
1 item of media coverage
Press/Media: Press / Media
Australia Patent for 'Pyridin-2-YL-Methlyamine derivatives for treating opioid dependence' Ceases
2/8/16
2 items of media coverage
Press/Media: Press / Media